{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:23:46Z","timestamp":1760149426725,"version":"build-2065373602"},"publisher-location":"Basel Switzerland","reference-count":15,"publisher":"MDPI","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for Science and Technology (FCT), I.P., Portugal","award":["UIDB\/04138\/2020","UIDB\/04585\/2020","SFRH\/BD\/131062\/2017"],"award-info":[{"award-number":["UIDB\/04138\/2020","UIDB\/04585\/2020","SFRH\/BD\/131062\/2017"]}]},{"name":"PhD fellowship from FCT, Portugal","award":["UIDB\/04138\/2020","UIDB\/04585\/2020","SFRH\/BD\/131062\/2017"],"award-info":[{"award-number":["UIDB\/04138\/2020","UIDB\/04585\/2020","SFRH\/BD\/131062\/2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3390\/msf2023022023","type":"proceedings-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T10:11:15Z","timestamp":1692007875000},"page":"23","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Compound Combining an Integrase-Targeting Aptamer and a Small Interfering RNA Targeting the Trans-Activation Response\/Poly A Region of HIV-1 Potently Suppresses HIV-1 Replication"],"prefix":"10.3390","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-0670","authenticated-orcid":false,"given":"In\u00eas","family":"Moranguinho","sequence":"first","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1600-277 Lisbon, Portugal"}]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1600-277 Lisbon, Portugal"},{"name":"Centro de Administra\u00e7\u00e3o e Pol\u00edticas P\u00fablicas (CAPP), Instituto Superior de Ci\u00eancias Sociais e Pol\u00edticas, Universidade de Lisboa, 1300-666 Lisbon, Portugal"}]},{"given":"Jo\u00e3o","family":"Lavrado","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1600-277 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-9852","authenticated-orcid":false,"given":"Rui","family":"Moreira","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1600-277 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-5585","authenticated-orcid":false,"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1600-277 Lisbon, Portugal"},{"name":"Centro de Investiga\u00e7\u00e3o Interdisciplinar Egas Moniz (CiiEM), Instituto Universit\u00e1rio Egas Moniz, 2829-511 Caparica, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Moranguinho, I., and Valente, S.T. (2020). Block-And-Lock: New Horizons for a Cure for HIV-1. Viruses, 12.","DOI":"10.3390\/v12121443"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Schuster, S., Miesen, P., and van Rij, R.P. (2019). Antiviral RNAi in Insects and Mammals: Parallels and Differences. Viruses, 11.","DOI":"10.3390\/v11050448"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17460441.2022.2117296","article-title":"The discovery and development of RNA-based therapies for treatment of HIV-1 infection","volume":"18","author":"Chen","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-4690-4-80","article-title":"Optimal design and validation of antiviral siRNA for targeting HIV-1","volume":"4","author":"Naito","year":"2007","journal-title":"Retrovirology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/wnan.1438","article-title":"Advances in the development of aptamer drug conjugates for targeted drug delivery","volume":"9","author":"Chen","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotech."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40824-021-00244-4","article-title":"Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy","volume":"25","author":"Kim","year":"2021","journal-title":"Biomater. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rozina, A., Anisenko, A., Kikhai, T., Silkina, M., and Gottikh, M. (2022). Complex Relationships between HIV-1 Integrase and Its Cellular Partners. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012341"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-2432-5_11","article-title":"Aptamer-siRNA chimeras for HIV","volume":"848","author":"Takahashi","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/mt.2011.207","article-title":"Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice","volume":"19","author":"Zhou","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1128\/JVI.00650-11","article-title":"The HIV-1 Tat protein has a versatile role in activating viral transcription","volume":"85","author":"Das","year":"2011","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34992","DOI":"10.1074\/jbc.273.52.34992","article-title":"Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic Drug","volume":"273","author":"Jing","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/mt.2008.92","article-title":"Novel Dual Inhibitory Function Aptamer\u2013siRNA Delivery System for HIV-1 Therapy","volume":"16","author":"Zhou","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/mtna.2015.1","article-title":"High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication","volume":"4","author":"Duclair","year":"2015","journal-title":"Mol. Ther.-Nucleic Acids"}],"event":{"name":"International Congress of CiiEM","acronym":"CiiEM 2023"},"container-title":["The 6th International Congress of CiiEM—Immediate and Future Challenges to Foster One Health"],"original-title":[],"link":[{"URL":"https:\/\/www.mdpi.com\/2673-9992\/22\/1\/23\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:33:01Z","timestamp":1760128381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-9992\/22\/1\/23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":15,"alternative-id":["msf2023022023"],"URL":"https:\/\/doi.org\/10.3390\/msf2023022023","relation":{},"subject":[],"published":{"date-parts":[[2023,8,11]]}}}